콘텐츠로 건너뛰기
주식/증권 📈 긍정적

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up

요약

TXG beats Q2 earnings and revenue estimates, expands gross margin and raises its 2026 revenue outlook despite a year-over-year sales decline.